PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
AffiliationSchool of Public Health, Physiotherapy & Population Science, UCD Veterinary Sciences Centre, University College Dublin, Belfield, Dublin 4, Ireland. email@example.com
MeSHAmino Acid Substitution
Drug Resistance, Bacterial
Microbial Sensitivity Tests
Reverse Transcriptase Polymerase Chain Reaction
MetadataShow full item record
CitationPCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. 2011, 66 (9):1976-82 J. Antimicrob. Chemother.
JournalThe Journal of antimicrobial chemotherapy
AbstractAntimicrobial use is recognized as a risk factor for Clostridium difficile infection (CDI) and outbreaks. We studied the relationship between PCR ribotype, antimicrobial susceptibility and the genetic basis of resistance in response to exposure to antimicrobial agents.
- Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance.
- Authors: Pituch H, Brazier JS, Obuch-Woszczatynski P, Wultanska D, Meisel-Mikolajczyk F, Luczak M
- Issue date: 2006 Feb
- Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
- Authors: Spigaglia P, Barbanti F, Dionisi AM, Mastrantonio P
- Issue date: 2010 Aug
- The epidemiology of Clostridium difficile in Scotland.
- Authors: Wiuff C, Brown DJ, Mather H, Banks AL, Eastaway A, Coia JE
- Issue date: 2011 Apr
- Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
- Authors: Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren AC, Weintraub A, Nord CE
- Issue date: 2009 Apr
- High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
- Authors: Drudy D, Quinn T, O'Mahony R, Kyne L, O'Gaora P, Fanning S
- Issue date: 2006 Dec